181 results
Page 7 of 10
6-K
EX-99.1
gujulw8k 330k
14 Nov 18
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
8:05am
6-K
EX-99.1
cbqdq1
14 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.2
15gm99p ujs4v
14 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.1
zbmh74e
7 Nov 18
Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference Call
8:01am
6-K
EX-99.1
3veea
23 Oct 18
Acasti Pharma Announces Closing of C$27.6 Million Underwritten Public Offering of Common Shares Including the Exercise of the Over-Allotment Option
9:21am
POS AM
8hl0caje8ku902
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
6-K
EX-99.1
ick 1hj7q6q
11 Oct 18
Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
7:42am
424B5
k4dtz
5 Oct 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
w9t2itn 7rln0vq55i
4 Oct 18
Acasti Pharma Prices C$24 Million Underwritten Offering
11:00am
6-K
EX-99.1
fit0jonzh
4 Oct 18
Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares
11:00am
6-K
EX-99.1
uqs7an aw9s
3 Oct 18
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
5:15pm
6-K
EX-99.1
6io12 wbrd41fm
3 Oct 18
Acasti Pharma Announces Public Equity Offering
5:15pm
424B5
qwyi1wc knr
3 Oct 18
Prospectus supplement for primary offering
4:51pm
6-K
EX-99.1
y03vb4cz1oess8k zth4
1 Oct 18
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
5:00pm
6-K
EX-99.1
su3 6323xr9r
24 Sep 18
Acasti Pharma Appoints Jean-François Boily as Vice President of Finance
8:05am
6-K
EX-99.1
ba9xo2
14 Aug 18
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2019
1:04pm
6-K
EX-99.1
pq2i6jobpkr3w4b
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.2
zh1i yywea0
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.2
49pp1e80 be2
1 Aug 18
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
olmtrhs gw8f
31 Jul 18
Acasti Pharma Announces Mailing of Management Information Circular and Amendment to Stock Option Plan
5:14pm